EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

α2,3‐Sialyltransferase ( ST3Gal1 ) regulates endometrioid‐type epithelial ovarian cancer cell migration and invasion via VEGF ‐ R2 / JAK2 / STAT3 signaling cascades

Wei-Ting Chao iD, Chia-Hao Liu, Szu-Ting Yang, Chen-Hao Lin, Liang-Wei Wang, Peng-Hui Wang iD

International Journal of Gynecology & Obstetrics · 2026

DOI: 10.1002/ijgo.71057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, 2026. Verfasst von Wei-Ting Chao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Sialyltransferases, Ovarian Neoplasms, Vascular Endothelial Growth Factor Receptor-2, Carcinoma, Ovarian Epithelial. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taipei Veterans General Hospital, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the role of ST3 β‐galactoside α‐2,3‐sialyltransferase 1 (ST3Gal1) and vascular endothelial growth factor receptor 2 (VEGF‐R2) in endometrioid‐type epithelial ovarian cancer (E‐OC) because aberrant α2,3‐sialylation mediated by ST3Gal1 and VEGF‐R2‐related angiogenesis is linked with tumor progression.

Methods

ST3Gal1 and VEGF‐R2 expression levels were analyzed in E‐OC tissues and cell lines. ST3Gal1 knockdown and ST3Gal1 inhibitor soyasaponin I (SsaI) treatment were performed to evaluate the effects of altered sialylation on the VEGF‐R2 pathway, downstream Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling, and cell migration/invasion. Co‐immunoprecipitation experiments were conducted to confirm the interaction between ST3Gal1 and VEGF‐R2. The combination of SsaI and VEGF‐R2 inhibitors was assessed using in vitro and in vivo studies.

Results

High ST3Gal1 expression was associated with advanced E‐OC stage and poorer overall survival in a univariable analysis; however, it did not retain independent prognostic significance in a multivariable analysis. ST3Gal1 knockdown reduced VEGF‐R2 expression and inhibited downstream JAK2/STAT3 signaling and suppressed tumor cell migration and invasion. SsaI treatment reduced VEGF‐R2 signaling and impaired metastatic potential in vitro. The combined inhibition of ST3Gal1 and VEGF‐R2 reduced tumor growth in vivo.

Conclusions

Targeting ST3Gal1‐mediated α2,3‐sialylation disrupts VEGF‐R2 signaling and suppresses metastatic behavior in E‐OC models. Although clinical associations suggest a potential link with adverse outcomes, larger studies are required to clarify its independent prognostic significance. Combined inhibition of ST3Gal1 and VEGF‐R2 reduced tumor growth in vivo; these findings support further investigations of ST3Gal1 as a potential therapeutic target in E‐OC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SialyltransferasesOvarian NeoplasmsVascular Endothelial Growth Factor Receptor-2Carcinoma, Ovarian EpithelialFemaleHumansCell Movementbeta-Galactoside alpha-2,3-SialyltransferaseSignal TransductionAnimalsSTAT3 Transcription FactorJanus Kinase 2Cell Line, TumorNeoplasm InvasivenessMiceMice, Nude

Stichwörter der Autor:innen

ST3Gal1VEGF‐R2/JAK2/STAT3 signalingangiogenesisendometrioid‐type epithelial ovarian cancerα2,3‐sialyltransferase

Substanzen

Sialyltransferasesbeta-Galactoside alpha-2,3-SialyltransferaseSTAT3 Transcription FactorJanus Kinase 2Vascular Endothelial Growth Factor Receptor-2ST3GAL1 protein, humanSTAT3 protein, humanJAK2 protein, humanKDR protein, human

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Department of Obstetrics and Gynecology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Taiwan Female Cancer Foundation, Taipei, Taiwan.
  • Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
  • Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.

ORCID-Profile: Wei-Ting Chao, Peng-Hui Wang

Förderung

  • Taipei Veterans General Hospital
  • National Science and Technology Council

Zitieren

APA

Chao, W. T., Liu, C. H., Yang, S. T., Lin, C. H., Wang, L. W., & Wang, P. H. (2026). α2,3‐Sialyltransferase ( ST3Gal1 ) regulates endometrioid‐type epithelial ovarian cancer cell migration and invasion via VEGF ‐ R2 / JAK2 / STAT3 signaling cascades. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.71057

Vancouver

Chao WT, Liu CH, Yang ST, Lin CH, Wang LW, Wang PH. α2,3‐Sialyltransferase ( ST3Gal1 ) regulates endometrioid‐type epithelial ovarian cancer cell migration and invasion via VEGF ‐ R2 / JAK2 / STAT3 signaling cascades. International Journal of Gynecology & Obstetrics. 2026. doi:10.1002/ijgo.71057

BibTeX
@article{Chao2026,
  author = {Chao, Wei-Ting and Liu, Chia-Hao and Yang, Szu-Ting and Lin, Chen-Hao and Wang, Liang-Wei and Wang, Peng-Hui},
  title = {α2,3‐Sialyltransferase ( ST3Gal1 ) regulates endometrioid‐type epithelial ovarian cancer cell migration and invasion via VEGF ‐ R2 / JAK2 / STAT3 signaling cascades},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2026},
  doi = {10.1002/ijgo.71057}
}
Kostenlos starten →